ArticleFrontiers in oncology2026

PD-L1-negative triple-negative breast cancer exhibited a remarkable response to cadonilimab: a case report.

Baohua Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.